Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid decay of tree-community composition in Amazonian forest fragments.
Laurance WF, Nascimento HE, Laurance SG, Andrade A, Ribeiro JE, Giraldo JP, Lovejoy TE, Condit R, Chave J, Harms KE, D'Angelo S. Laurance WF, et al. Among authors: ribeiro je. Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19010-4. doi: 10.1073/pnas.0609048103. Epub 2006 Dec 5. Proc Natl Acad Sci U S A. 2006. PMID: 17148598 Free PMC article.
Pervasive alteration of tree communities in undisturbed Amazonian forests.
Laurance WF, Oliveira AA, Laurance SG, Condit R, Nascimento HE, Sanchez-Thorin AC, Lovejoy TE, Andrade A, D'Angelo S, Ribeiro JE, Dick CW. Laurance WF, et al. Among authors: ribeiro je. Nature. 2004 Mar 11;428(6979):171-5. doi: 10.1038/nature02383. Nature. 2004. PMID: 15014498 Free article.
Time of Application of Desiccant Herbicides Affects Photosynthetic Pigments, Physiological Indicators, and the Quality of Cowpea Seeds.
Coêlho EDS, Ribeiro JEDS, Lopes WAR, Oliveira AKS, Oliveira PHA, Santos GLD, Barbosa EDS, Silva VNSE, Lins HA, Benedito CP, Silveira LMD, Araujo Filho AC, Silva DV, Barros Júnior AP. Coêlho EDS, et al. Among authors: ribeiro jeds. J Xenobiot. 2024 Sep 19;14(3):1312-1331. doi: 10.3390/jox14030074. J Xenobiot. 2024. PMID: 39311153 Free PMC article.
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES; ACTIV-2/A5401 Study Team. Evering TH, et al. Ann Intern Med. 2023 May;176(5):658-666. doi: 10.7326/M22-3428. Epub 2023 Apr 18. Ann Intern Med. 2023. PMID: 37068272 Free PMC article. Clinical Trial.
36 results